SANA compared with MCRB: revenue, margins and what each company keeps, and the suppliers and customers both name

SANASana Biotechnology, Inc.

Mkt capRevenueRevenue

MCRBSeres Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

SANASana Biotechnology, Inc.

MCRBSeres Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only SANA 11

BEAMBeam Therapeutics, Inc. (Beam)supplier

—Flagship Pioneering Innovations V, Inc. (Flagship)unlistedsupplier

—FUJIFILM Cellular Dynamics, Inc. (FCDI)unlistedsupplier

—La Societe Pulsalys (Pulsalys)unlistedsupplier

7 more · SANA chain ›

Shared 0

No shared counterparties.

Only MCRB 11

—Bactheraunlistedsupplier

—CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator)unlistedsupplier

—Crohn's and Colitis Foundationunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—Columbia Universityunlistedsupplier

7 more · MCRB chain ›

SANASana Biotechnology, Inc.

2.56▼−5.88%· post 2.56

Mkt cap$769.4MRevenue—

MCRBSeres Therapeutics, Inc.

1.76▼−9.72%· post 1.76

ClosedOct 30 '26

Mkt cap$17.6MRevenue$736,000Q2 FY26

Compare

ClosedOct 30 '26

SANASana Biotechnology, Inc.

MCRBSeres Therapeutics, Inc.

2.56▼−5.88%post 2.56

Price

1.76▼−9.72%post 1.76

$769.4M

Mkt cap

$17.6M

—

Revenue

$736,000Q2 FY26

SANA2.56▼−5.88%vsMCRB1.76▼−9.72%ClosedOct 30 '26